

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.40910279 |
| 2 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.40910279 |
| 3 | protein complex biogenesis (GO:0070271) | 3.97345688 |
| 4 | protein localization to cilium (GO:0061512) | 3.88340073 |
| 5 | cellular ketone body metabolic process (GO:0046950) | 3.85455194 |
| 6 | regulation of glucokinase activity (GO:0033131) | 3.74662703 |
| 7 | regulation of hexokinase activity (GO:1903299) | 3.74662703 |
| 8 | protein-cofactor linkage (GO:0018065) | 3.70680229 |
| 9 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.69008250 |
| 10 | NADH dehydrogenase complex assembly (GO:0010257) | 3.69008250 |
| 11 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.69008250 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 3.67269215 |
| 13 | platelet dense granule organization (GO:0060155) | 3.56257689 |
| 14 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.53644312 |
| 15 | S-adenosylmethionine metabolic process (GO:0046500) | 3.49431883 |
| 16 | inositol phosphate catabolic process (GO:0071545) | 3.44800004 |
| 17 | cysteine metabolic process (GO:0006534) | 3.41512933 |
| 18 | adenosine metabolic process (GO:0046085) | 3.41110469 |
| 19 | respiratory chain complex IV assembly (GO:0008535) | 3.38906631 |
| 20 | ketone body metabolic process (GO:1902224) | 3.38234761 |
| 21 | inositol phosphate dephosphorylation (GO:0046855) | 3.32965234 |
| 22 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.32965234 |
| 23 | homocysteine metabolic process (GO:0050667) | 3.32042918 |
| 24 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.31771168 |
| 25 | protein polyglutamylation (GO:0018095) | 3.20761129 |
| 26 | GPI anchor biosynthetic process (GO:0006506) | 3.19933675 |
| 27 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.16946862 |
| 28 | positive regulation of amino acid transport (GO:0051957) | 3.13919517 |
| 29 | regulation of cilium movement (GO:0003352) | 3.13263513 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 3.11837784 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.11837784 |
| 32 | peroxisome fission (GO:0016559) | 3.10675566 |
| 33 | positive regulation of mitochondrial fission (GO:0090141) | 3.06353054 |
| 34 | GPI anchor metabolic process (GO:0006505) | 3.03804325 |
| 35 | axoneme assembly (GO:0035082) | 3.03563336 |
| 36 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.00808114 |
| 37 | cytochrome complex assembly (GO:0017004) | 3.00465775 |
| 38 | microtubule nucleation (GO:0007020) | 3.00445745 |
| 39 | branched-chain amino acid catabolic process (GO:0009083) | 3.00242085 |
| 40 | glycerophospholipid catabolic process (GO:0046475) | 2.99587526 |
| 41 | short-chain fatty acid metabolic process (GO:0046459) | 2.99267618 |
| 42 | positive regulation of glycolytic process (GO:0045821) | 2.98502880 |
| 43 | endocrine pancreas development (GO:0031018) | 2.98210495 |
| 44 | purine nucleotide salvage (GO:0032261) | 2.97099455 |
| 45 | mannosylation (GO:0097502) | 2.96539381 |
| 46 | single strand break repair (GO:0000012) | 2.93372756 |
| 47 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.92685094 |
| 48 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.92685094 |
| 49 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.92300193 |
| 50 | epithelial cilium movement (GO:0003351) | 2.92004977 |
| 51 | rRNA modification (GO:0000154) | 2.91626501 |
| 52 | organic cation transport (GO:0015695) | 2.91032842 |
| 53 | rRNA methylation (GO:0031167) | 2.88820015 |
| 54 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.83848500 |
| 55 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.83587096 |
| 56 | response to pheromone (GO:0019236) | 2.80595935 |
| 57 | aromatic amino acid family catabolic process (GO:0009074) | 2.80471760 |
| 58 | aldehyde catabolic process (GO:0046185) | 2.73173143 |
| 59 | peptidyl-cysteine modification (GO:0018198) | 2.66936741 |
| 60 | polyol catabolic process (GO:0046174) | 2.65696812 |
| 61 | nucleobase catabolic process (GO:0046113) | 2.64416744 |
| 62 | L-phenylalanine metabolic process (GO:0006558) | 2.63957407 |
| 63 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.63957407 |
| 64 | neurotransmitter catabolic process (GO:0042135) | 2.61806582 |
| 65 | electron transport chain (GO:0022900) | 2.60073395 |
| 66 | respiratory electron transport chain (GO:0022904) | 2.58871796 |
| 67 | axonemal dynein complex assembly (GO:0070286) | 2.58256368 |
| 68 | mitochondrial RNA metabolic process (GO:0000959) | 2.58131376 |
| 69 | adaptation of signaling pathway (GO:0023058) | 2.57318038 |
| 70 | negative regulation of membrane potential (GO:0045837) | 2.56502206 |
| 71 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.56451026 |
| 72 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.56321918 |
| 73 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.55859936 |
| 74 | tryptophan catabolic process (GO:0006569) | 2.52590849 |
| 75 | indole-containing compound catabolic process (GO:0042436) | 2.52590849 |
| 76 | indolalkylamine catabolic process (GO:0046218) | 2.52590849 |
| 77 | positive regulation of insulin secretion (GO:0032024) | 2.51397071 |
| 78 | C-terminal protein lipidation (GO:0006501) | 2.50108112 |
| 79 | negative regulation of acute inflammatory response (GO:0002674) | 2.50041251 |
| 80 | inner mitochondrial membrane organization (GO:0007007) | 2.49951859 |
| 81 | intraciliary transport (GO:0042073) | 2.48443650 |
| 82 | branched-chain amino acid metabolic process (GO:0009081) | 2.47951647 |
| 83 | nonmotile primary cilium assembly (GO:0035058) | 2.44367300 |
| 84 | cilium movement (GO:0003341) | 2.42656110 |
| 85 | nitric oxide mediated signal transduction (GO:0007263) | 2.41311212 |
| 86 | dopamine transport (GO:0015872) | 2.41161931 |
| 87 | xenobiotic catabolic process (GO:0042178) | 2.40167845 |
| 88 | positive regulation of peptide hormone secretion (GO:0090277) | 2.39586220 |
| 89 | galactose catabolic process (GO:0019388) | 2.38201379 |
| 90 | spermatid nucleus differentiation (GO:0007289) | 2.37395491 |
| 91 | growth hormone secretion (GO:0030252) | 2.36751855 |
| 92 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.36526005 |
| 93 | regulation of plasminogen activation (GO:0010755) | 2.35667780 |
| 94 | detection of calcium ion (GO:0005513) | 2.35298930 |
| 95 | anterograde synaptic vesicle transport (GO:0048490) | 2.34237655 |
| 96 | polyamine metabolic process (GO:0006595) | 2.34103076 |
| 97 | response to lipoprotein particle (GO:0055094) | 2.32153035 |
| 98 | cullin deneddylation (GO:0010388) | 2.30830353 |
| 99 | serine family amino acid catabolic process (GO:0009071) | 2.29541732 |
| 100 | glycolipid biosynthetic process (GO:0009247) | 2.29040324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.82614476 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.72554839 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.71791955 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.66767009 |
| 5 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.60487474 |
| 6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.59661889 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.45555122 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.45124914 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.36156100 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.31998924 |
| 11 | FUS_26573619_Chip-Seq_HEK293_Human | 2.28668002 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.28381070 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.09098404 |
| 14 | EWS_26573619_Chip-Seq_HEK293_Human | 2.01158136 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.00964451 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.97684944 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96984896 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.95970241 |
| 19 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.78365617 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.74873679 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.73614033 |
| 22 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73019565 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.72599945 |
| 24 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.69442927 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62467610 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62219377 |
| 27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.59985031 |
| 28 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.57730397 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57549808 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54965842 |
| 31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53430174 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45539695 |
| 33 | NCOR_22424771_ChIP-Seq_293T_Human | 1.42144166 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41097867 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.39802991 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39668096 |
| 37 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.37192622 |
| 38 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.35679591 |
| 39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35623829 |
| 40 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35251525 |
| 41 | AR_20517297_ChIP-Seq_VCAP_Human | 1.32205932 |
| 42 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.31357206 |
| 43 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30473713 |
| 44 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30473713 |
| 45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.29619921 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28610409 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27361767 |
| 48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27361767 |
| 49 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.26400230 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24528436 |
| 51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23220374 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22907229 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22863777 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22357042 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22353017 |
| 56 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22084401 |
| 57 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.21548429 |
| 58 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.21548429 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16154679 |
| 60 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.15902905 |
| 61 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.15136511 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15051872 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14188595 |
| 64 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13774354 |
| 65 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13323176 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12776639 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12740868 |
| 68 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.11835429 |
| 69 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10784501 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10750603 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10723286 |
| 72 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08650304 |
| 73 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07813284 |
| 74 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.07631300 |
| 75 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07322591 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07024642 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06871563 |
| 78 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06532898 |
| 79 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05905625 |
| 80 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05772679 |
| 81 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04535363 |
| 82 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04210068 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99897337 |
| 84 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99071164 |
| 85 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.98974060 |
| 86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98520613 |
| 87 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97121872 |
| 88 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96685963 |
| 89 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96291755 |
| 90 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.96065399 |
| 91 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95579047 |
| 92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95075372 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92216146 |
| 94 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92057494 |
| 95 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.91822994 |
| 96 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.91812923 |
| 97 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.91452632 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.90088571 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89997915 |
| 100 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89871331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005646_abnormal_pituitary_gland | 3.12011712 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.07843056 |
| 3 | MP0003787_abnormal_imprinting | 2.67691861 |
| 4 | MP0002822_catalepsy | 2.63829251 |
| 5 | MP0003195_calcinosis | 2.61601938 |
| 6 | MP0000013_abnormal_adipose_tissue | 2.19677391 |
| 7 | MP0008877_abnormal_DNA_methylation | 2.15718871 |
| 8 | MP0002102_abnormal_ear_morphology | 2.12124959 |
| 9 | MP0008995_early_reproductive_senescence | 2.10760981 |
| 10 | MP0002909_abnormal_adrenal_gland | 2.10570463 |
| 11 | MP0003880_abnormal_central_pattern | 2.08129436 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.04226942 |
| 13 | MP0006072_abnormal_retinal_apoptosis | 2.01623133 |
| 14 | MP0001986_abnormal_taste_sensitivity | 1.94970915 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 1.94629444 |
| 16 | MP0004147_increased_porphyrin_level | 1.90485735 |
| 17 | MP0005551_abnormal_eye_electrophysiolog | 1.90339301 |
| 18 | MP0002876_abnormal_thyroid_physiology | 1.84193087 |
| 19 | MP0001984_abnormal_olfaction | 1.83217875 |
| 20 | MP0001764_abnormal_homeostasis | 1.82839862 |
| 21 | MP0005379_endocrine/exocrine_gland_phen | 1.81705504 |
| 22 | MP0004043_abnormal_pH_regulation | 1.76297984 |
| 23 | MP0005253_abnormal_eye_physiology | 1.73067286 |
| 24 | MP0005332_abnormal_amino_acid | 1.72261133 |
| 25 | MP0003122_maternal_imprinting | 1.69289059 |
| 26 | MP0009046_muscle_twitch | 1.66247841 |
| 27 | MP0003011_delayed_dark_adaptation | 1.64932962 |
| 28 | MP0002139_abnormal_hepatobiliary_system | 1.63858413 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.62317552 |
| 30 | MP0005670_abnormal_white_adipose | 1.55810360 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.53787080 |
| 32 | MP0002938_white_spotting | 1.53254455 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.51993634 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.51983059 |
| 35 | MP0008058_abnormal_DNA_repair | 1.48278706 |
| 36 | MP0005220_abnormal_exocrine_pancreas | 1.47641048 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.46332513 |
| 38 | MP0001944_abnormal_pancreas_morphology | 1.45814277 |
| 39 | MP0003283_abnormal_digestive_organ | 1.43253597 |
| 40 | MP0001905_abnormal_dopamine_level | 1.42848596 |
| 41 | MP0009745_abnormal_behavioral_response | 1.41276032 |
| 42 | MP0001529_abnormal_vocalization | 1.40910408 |
| 43 | MP0005410_abnormal_fertilization | 1.38589581 |
| 44 | MP0001756_abnormal_urination | 1.35841076 |
| 45 | MP0004885_abnormal_endolymph | 1.35354247 |
| 46 | MP0008872_abnormal_physiological_respon | 1.34391985 |
| 47 | MP0002693_abnormal_pancreas_physiology | 1.34034824 |
| 48 | MP0003186_abnormal_redox_activity | 1.33947137 |
| 49 | MP0001486_abnormal_startle_reflex | 1.32210752 |
| 50 | MP0000516_abnormal_urinary_system | 1.29044805 |
| 51 | MP0005367_renal/urinary_system_phenotyp | 1.29044805 |
| 52 | MP0000372_irregular_coat_pigmentation | 1.27357565 |
| 53 | MP0003121_genomic_imprinting | 1.25897252 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 1.25468331 |
| 55 | MP0002095_abnormal_skin_pigmentation | 1.24381974 |
| 56 | MP0002272_abnormal_nervous_system | 1.23213973 |
| 57 | MP0002229_neurodegeneration | 1.21715870 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.21538095 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.21007208 |
| 60 | MP0001968_abnormal_touch/_nociception | 1.18275235 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18058819 |
| 62 | MP0002132_abnormal_respiratory_system | 1.11723264 |
| 63 | MP0001661_extended_life_span | 1.11359231 |
| 64 | MP0002163_abnormal_gland_morphology | 1.08989913 |
| 65 | MP0004133_heterotaxia | 1.08896977 |
| 66 | MP0002160_abnormal_reproductive_system | 1.06642309 |
| 67 | MP0004142_abnormal_muscle_tone | 1.06253025 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.05176765 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.04184476 |
| 70 | MP0005535_abnormal_body_temperature | 1.03029381 |
| 71 | MP0005365_abnormal_bile_salt | 1.02853790 |
| 72 | MP0002572_abnormal_emotion/affect_behav | 1.01171815 |
| 73 | MP0003646_muscle_fatigue | 1.00952623 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 1.00918541 |
| 75 | MP0002064_seizures | 0.99666673 |
| 76 | MP0000631_abnormal_neuroendocrine_gland | 0.99259645 |
| 77 | MP0010329_abnormal_lipoprotein_level | 0.95934815 |
| 78 | MP0003698_abnormal_male_reproductive | 0.93147392 |
| 79 | MP0003724_increased_susceptibility_to | 0.92949893 |
| 80 | MP0002557_abnormal_social/conspecific_i | 0.92819866 |
| 81 | MP0001485_abnormal_pinna_reflex | 0.92406254 |
| 82 | MP0001970_abnormal_pain_threshold | 0.92146171 |
| 83 | MP0005085_abnormal_gallbladder_physiolo | 0.90963302 |
| 84 | MP0003123_paternal_imprinting | 0.90529476 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.89622475 |
| 86 | MP0005386_behavior/neurological_phenoty | 0.89065929 |
| 87 | MP0004924_abnormal_behavior | 0.89065929 |
| 88 | MP0002736_abnormal_nociception_after | 0.88902182 |
| 89 | MP0001188_hyperpigmentation | 0.88216352 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.87966184 |
| 91 | MP0003953_abnormal_hormone_level | 0.87093184 |
| 92 | MP0004270_analgesia | 0.86708795 |
| 93 | MP0003718_maternal_effect | 0.86323357 |
| 94 | MP0003633_abnormal_nervous_system | 0.85405236 |
| 95 | MP0005389_reproductive_system_phenotype | 0.84457804 |
| 96 | MP0002090_abnormal_vision | 0.83936397 |
| 97 | MP0001929_abnormal_gametogenesis | 0.83021800 |
| 98 | MP0002653_abnormal_ependyma_morphology | 0.82289171 |
| 99 | MP0002063_abnormal_learning/memory/cond | 0.81573387 |
| 100 | MP0004145_abnormal_muscle_electrophysio | 0.78622420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.46402486 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 4.46402486 |
| 3 | Hyperalaninemia (HP:0003348) | 4.46402486 |
| 4 | Medial flaring of the eyebrow (HP:0010747) | 3.28218563 |
| 5 | Constricted visual fields (HP:0001133) | 3.25972422 |
| 6 | Ketoacidosis (HP:0001993) | 3.17515948 |
| 7 | Hepatic necrosis (HP:0002605) | 3.13706508 |
| 8 | Tubulointerstitial nephritis (HP:0001970) | 3.03535398 |
| 9 | Methylmalonic acidemia (HP:0002912) | 2.87955384 |
| 10 | Generalized aminoaciduria (HP:0002909) | 2.86704691 |
| 11 | Mitochondrial inheritance (HP:0001427) | 2.82170789 |
| 12 | Pancreatic fibrosis (HP:0100732) | 2.81678093 |
| 13 | Hepatocellular necrosis (HP:0001404) | 2.79609285 |
| 14 | Congenital sensorineural hearing impairment (HP:0008527) | 2.71409603 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 2.69313791 |
| 16 | Chronic hepatic failure (HP:0100626) | 2.68621458 |
| 17 | Hypoglycemic coma (HP:0001325) | 2.67097260 |
| 18 | Progressive macrocephaly (HP:0004481) | 2.66883881 |
| 19 | Hypothermia (HP:0002045) | 2.66005608 |
| 20 | Gait imbalance (HP:0002141) | 2.64752959 |
| 21 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.62796126 |
| 22 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.62796126 |
| 23 | Nephronophthisis (HP:0000090) | 2.61879840 |
| 24 | Hypomagnesemia (HP:0002917) | 2.61691602 |
| 25 | Pancreatic cysts (HP:0001737) | 2.58259654 |
| 26 | Congenital primary aphakia (HP:0007707) | 2.58208264 |
| 27 | Increased CSF lactate (HP:0002490) | 2.57111462 |
| 28 | Nephrogenic diabetes insipidus (HP:0009806) | 2.53708042 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.53244528 |
| 30 | True hermaphroditism (HP:0010459) | 2.52142537 |
| 31 | Acute encephalopathy (HP:0006846) | 2.48635561 |
| 32 | Ketosis (HP:0001946) | 2.47988203 |
| 33 | Renal Fanconi syndrome (HP:0001994) | 2.45280043 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 2.44729730 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 2.44729730 |
| 36 | Glycosuria (HP:0003076) | 2.44696549 |
| 37 | Abnormality of urine glucose concentration (HP:0011016) | 2.44696549 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44317933 |
| 39 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.34591853 |
| 40 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34210158 |
| 41 | Lipid accumulation in hepatocytes (HP:0006561) | 2.30983304 |
| 42 | Attenuation of retinal blood vessels (HP:0007843) | 2.30947897 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.30694348 |
| 44 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.27701912 |
| 45 | Lactic acidosis (HP:0003128) | 2.27456415 |
| 46 | Hypoglycemic seizures (HP:0002173) | 2.27013073 |
| 47 | Hyperglycinemia (HP:0002154) | 2.24306033 |
| 48 | Hyperglycemia (HP:0003074) | 2.19774172 |
| 49 | Increased serum lactate (HP:0002151) | 2.19611225 |
| 50 | Methylmalonic aciduria (HP:0012120) | 2.16999131 |
| 51 | Hyperphosphaturia (HP:0003109) | 2.15892889 |
| 52 | Abnormality of vitamin B metabolism (HP:0004340) | 2.14596339 |
| 53 | Abolished electroretinogram (ERG) (HP:0000550) | 2.14046885 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 2.11987106 |
| 55 | Homocystinuria (HP:0002156) | 2.11716241 |
| 56 | Abnormality of homocysteine metabolism (HP:0010919) | 2.11716241 |
| 57 | Cerebral edema (HP:0002181) | 2.11445313 |
| 58 | Symptomatic seizures (HP:0011145) | 2.10271119 |
| 59 | Abnormality of the renal medulla (HP:0100957) | 2.04644693 |
| 60 | Abnormality of magnesium homeostasis (HP:0004921) | 2.02232799 |
| 61 | Large for gestational age (HP:0001520) | 1.98151716 |
| 62 | Renal cortical cysts (HP:0000803) | 1.96325302 |
| 63 | Agitation (HP:0000713) | 1.95343835 |
| 64 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.95111305 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94917820 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 1.94917820 |
| 67 | Thyroiditis (HP:0100646) | 1.94130600 |
| 68 | Abnormal drinking behavior (HP:0030082) | 1.92883186 |
| 69 | Polydipsia (HP:0001959) | 1.92883186 |
| 70 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.91636453 |
| 71 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.90742730 |
| 72 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.90742730 |
| 73 | Lethargy (HP:0001254) | 1.89713760 |
| 74 | 3-Methylglutaconic aciduria (HP:0003535) | 1.87989599 |
| 75 | Metabolic acidosis (HP:0001942) | 1.87989070 |
| 76 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87613866 |
| 77 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87591676 |
| 78 | Absent/shortened dynein arms (HP:0200106) | 1.87591676 |
| 79 | Abnormal ciliary motility (HP:0012262) | 1.87320718 |
| 80 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.83066502 |
| 81 | Polyphagia (HP:0002591) | 1.82866781 |
| 82 | Genital tract atresia (HP:0001827) | 1.81444791 |
| 83 | Heterochromia iridis (HP:0001100) | 1.80511828 |
| 84 | Oligomenorrhea (HP:0000876) | 1.80470232 |
| 85 | Proximal tubulopathy (HP:0000114) | 1.80326545 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80110001 |
| 87 | Muscular hypotonia of the trunk (HP:0008936) | 1.78430552 |
| 88 | Hemiparesis (HP:0001269) | 1.76966943 |
| 89 | Patchy hypopigmentation of hair (HP:0011365) | 1.75339153 |
| 90 | Metaphyseal dysplasia (HP:0100255) | 1.74881294 |
| 91 | Abnormality of renal resorption (HP:0011038) | 1.72816077 |
| 92 | White forelock (HP:0002211) | 1.72308073 |
| 93 | Vaginal atresia (HP:0000148) | 1.71499210 |
| 94 | Tetany (HP:0001281) | 1.71210915 |
| 95 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.69590774 |
| 96 | Tubulointerstitial abnormality (HP:0001969) | 1.67727264 |
| 97 | Bile duct proliferation (HP:0001408) | 1.66292908 |
| 98 | Abnormal biliary tract physiology (HP:0012439) | 1.66292908 |
| 99 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.65747500 |
| 100 | Exercise intolerance (HP:0003546) | 1.64351246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.99072066 |
| 2 | MAP4K2 | 4.15059214 |
| 3 | TRIM28 | 2.77347022 |
| 4 | ERBB3 | 2.16318404 |
| 5 | BCKDK | 2.14880514 |
| 6 | PINK1 | 2.11350366 |
| 7 | WNK3 | 2.05837833 |
| 8 | ACVR1B | 1.91125585 |
| 9 | DAPK2 | 1.88006775 |
| 10 | MAP3K4 | 1.85629336 |
| 11 | PHKG2 | 1.81621749 |
| 12 | PHKG1 | 1.81621749 |
| 13 | FGFR2 | 1.77315357 |
| 14 | EIF2AK3 | 1.73052615 |
| 15 | NUAK1 | 1.71759087 |
| 16 | GRK1 | 1.71283259 |
| 17 | CAMKK2 | 1.71116731 |
| 18 | NTRK3 | 1.67623327 |
| 19 | ADRBK2 | 1.60617373 |
| 20 | EPHA3 | 1.57249826 |
| 21 | MST4 | 1.55747286 |
| 22 | STK16 | 1.53979014 |
| 23 | PRKD3 | 1.53479052 |
| 24 | CSNK1G3 | 1.49122600 |
| 25 | CSNK1G2 | 1.42524809 |
| 26 | MAP2K7 | 1.39713119 |
| 27 | TAOK3 | 1.32336032 |
| 28 | VRK2 | 1.28295793 |
| 29 | STK39 | 1.27806586 |
| 30 | CSNK1G1 | 1.25002518 |
| 31 | DYRK2 | 1.23716011 |
| 32 | BCR | 1.22486932 |
| 33 | PAK3 | 1.21830557 |
| 34 | MAPK13 | 1.21657084 |
| 35 | PLK2 | 1.19977234 |
| 36 | CCNB1 | 1.16278293 |
| 37 | PRKCE | 1.13794746 |
| 38 | ZAK | 1.13202083 |
| 39 | OBSCN | 1.10747109 |
| 40 | PDK2 | 1.07594505 |
| 41 | TLK1 | 1.07512699 |
| 42 | FER | 1.01890582 |
| 43 | OXSR1 | 1.01734183 |
| 44 | CSNK1A1L | 0.99363943 |
| 45 | WNK4 | 0.95912071 |
| 46 | INSRR | 0.95386131 |
| 47 | CASK | 0.93467879 |
| 48 | BMPR1B | 0.91817573 |
| 49 | PRKCG | 0.91776447 |
| 50 | PASK | 0.90445505 |
| 51 | VRK1 | 0.90215893 |
| 52 | TAF1 | 0.85849959 |
| 53 | SGK2 | 0.82745989 |
| 54 | SGK223 | 0.82112654 |
| 55 | SGK494 | 0.82112654 |
| 56 | BRSK2 | 0.81827474 |
| 57 | MUSK | 0.78786937 |
| 58 | NTRK2 | 0.76802147 |
| 59 | CDK9 | 0.74212171 |
| 60 | DYRK3 | 0.72824543 |
| 61 | TNK2 | 0.72799162 |
| 62 | LIMK1 | 0.71544221 |
| 63 | TEC | 0.68967714 |
| 64 | UHMK1 | 0.64693898 |
| 65 | STK38L | 0.63749182 |
| 66 | PRKCI | 0.62330032 |
| 67 | PIM2 | 0.61228400 |
| 68 | CSNK1A1 | 0.60584346 |
| 69 | GRK7 | 0.58762342 |
| 70 | TXK | 0.57287498 |
| 71 | RPS6KA5 | 0.53592520 |
| 72 | MARK1 | 0.52692346 |
| 73 | JAK3 | 0.51453512 |
| 74 | MAP3K11 | 0.51442201 |
| 75 | IKBKB | 0.51342653 |
| 76 | PRKAA2 | 0.50875692 |
| 77 | GRK5 | 0.49818212 |
| 78 | CAMK2A | 0.49404070 |
| 79 | MAP2K4 | 0.49394935 |
| 80 | PRKAA1 | 0.48218083 |
| 81 | CAMK2D | 0.47348616 |
| 82 | PRKACA | 0.47115525 |
| 83 | DYRK1B | 0.46373635 |
| 84 | AKT3 | 0.45851530 |
| 85 | MAP3K12 | 0.45018294 |
| 86 | PLK4 | 0.44933606 |
| 87 | STK24 | 0.44901840 |
| 88 | MAPK15 | 0.44511591 |
| 89 | PRKCQ | 0.43623750 |
| 90 | LMTK2 | 0.41628443 |
| 91 | STK11 | 0.39620905 |
| 92 | MINK1 | 0.37863980 |
| 93 | PLK3 | 0.36467315 |
| 94 | DAPK1 | 0.36260767 |
| 95 | TESK1 | 0.34888507 |
| 96 | CDK5 | 0.34808737 |
| 97 | ADRBK1 | 0.34625067 |
| 98 | PTK2B | 0.34593549 |
| 99 | PRKCA | 0.32422948 |
| 100 | PRKG1 | 0.31749167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.05618733 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.94147800 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.83412766 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.79522026 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.72839597 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42734422 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.38165964 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.26989684 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.18296320 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.17922348 |
| 11 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.17313714 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.17074307 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.94493812 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.86076851 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.62154029 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.53955395 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.49074526 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.47146193 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.42897446 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38569040 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38263138 |
| 22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.37564268 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37495780 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.36321116 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.32994444 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.31300282 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.30095251 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27582178 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.27548034 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.23440914 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.22631203 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.21918539 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18168213 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17834703 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.16856096 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.14637480 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13788702 |
| 38 | Morphine addiction_Homo sapiens_hsa05032 | 1.12526524 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.11462296 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11333903 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 1.10114931 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.07028269 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03269801 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02584472 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01762079 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01572764 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00022529 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98273919 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 0.97141488 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94357654 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 0.89157094 |
| 52 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89055487 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87816778 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86971288 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86623772 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85102222 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.84538177 |
| 58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83658013 |
| 59 | Circadian entrainment_Homo sapiens_hsa04713 | 0.83331050 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82956698 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82440458 |
| 62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.81416262 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80539293 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78670792 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78564331 |
| 66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76676081 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.75912627 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75604553 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73409767 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73349829 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71089007 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70364280 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69180480 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68125199 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66335590 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.66157214 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63581790 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63525820 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61500862 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.61138171 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59109346 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58981326 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58739209 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58611017 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58328005 |
| 86 | RNA polymerase_Homo sapiens_hsa03020 | 0.56532165 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55896515 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54456143 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.54432635 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51774158 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51129720 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51041795 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50776978 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.49919166 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47576647 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46841398 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45717750 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45096222 |
| 99 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40154585 |
| 100 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.33666118 |

